Differential Expression and Effects of Peroxiredoxin-6 on Drug Resistance and Cancer Stem Cell-Like Properties in Non-Small Cell Lung Cancer

OncoTargets and Therapy - New Zealand
doi 10.2147/ott.s211125
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Cancer Stem Cells in Lung Cancer: Distinct Differences Between Small Cell and Non-Small Cell Lung Carcinomas

2011English

Novel Drug-Resistance Mechanisms of Pemetrexed-Treated Non-Small Cell Lung Cancer

Oncotarget
Oncology
2018English

Non-Small Cell Lung Cancer-Small Cell Lung Cancer Transformation as Mechanism of Resistance to Tyrosine Kinase Inhibitors in Lung Cancer

2020English

Epigenetic Activation of FOXF1 Confers Cancer Stem Cell Properties to Cisplatin‑resistant Non‑small Cell Lung Cancer

International Journal of Oncology
Cancer ResearchOncology
2020English

Drug Resistance in Non-Small Cell Lung Cancer: A Potential for NOTCH Targeting?

Frontiers in Oncology
Cancer ResearchOncology
2018English

Expression of Bone Morphogenetic Protein 6 in Non‑small Cell Lung Cancer and Its Significance

Oncology Letters
Cancer ResearchOncology
2018English

Effects of AKT Inhibition on HGF-mediated Erlotinib Resistance in Non-Small Cell Lung Cancer Cell Lines

Journal of Cancer Research and Clinical Oncology
MedicineCancer ResearchOncology
2014English

Drug Combination Synergy in Worm-Like Polymeric Micelles Improves Treatment Outcome for Small Cell and Non-Small Cell Lung Cancer

ACS Nano
Materials ScienceNanoscienceEngineeringNanotechnologyAstronomyPhysics
2018English

Differential Effects of MTSS1 on Invasion and Proliferation in Subtypes of Non-Small Cell Lung Cancer Cells

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy